US Federal 2025-2026 Regular Session

US Federal House Bill HB5187

Introduced
9/8/25  

Caption

To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

Impact

The implementation of HB 5187 is expected to have a significant impact on state laws pertaining to manufacturing and defense. By promoting the expansion of domestic bioindustrial production, the bill is likely to enhance local economies and decrease reliance on foreign suppliers for critical goods. The program's competitive award system aims to incentivize innovation in biomanufacturing technologies, which could stimulate advancements in health, military logistics, and emergency preparedness. Moreover, the focus on domestic capacity aligns with broader state and national goals of improving industrial self-sufficiency and innovation.

Summary

House Bill 5187 aims to establish a program within the Department of Defense to enhance domestic bioindustrial manufacturing capacity. This initiative is designed to support the production of critical biomanufactured products at a commercial level. The bill calls for the Secretary of Defense to create a framework through which eligible entities can apply for awards to establish, upgrade, or retool manufacturing facilities. The program is intended to bolster the resilience of supply chains essential for national defense and to address the growing demand for biomanufactured goods.

Contention

There are potential points of contention surrounding HB 5187, primarily regarding how the awards will be allocated and the criteria to evaluate eligible entities. Concerns may arise from stakeholders regarding fairness and transparency in the selection process. Additionally, there could be debates over the prioritization of particular technologies or products deemed critical by the Department of Defense. Such discussions may involve considerations of environmental impact and the implications for existing manufacturers and supply chains, as the bill seeks to overhaul current industrial practices to meet new defense needs.

Companion Bills

US HB3838

Related Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 Anti-CBDC Surveillance State Act Coast Guard Authorization Act of 2025 SAFE Research Act

Previously Filed As

US HB6664

To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

US HB7936

Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026

US HR11

Urge Ohio expansion of manufacturing of domestic drones

US HB5186

To authorize the Secretary of Defense to carry out a program to support the defense biotechnology supply chain, and for other purposes.

US A4603

Establishes "Support for Victims of Domestic Violence Program"; incentivizes certain businesses to provide support to individuals who are victims of domestic violence.

US SB998

Providing for the Nurse Education Capacity Expansion Grant Program; and imposing duties on the Department of Community and Economic Development.

US S1259

Supports activities of New Jersey Manufacturing Extension Program, Inc.

US A2655

Supports activities of New Jersey Manufacturing Extension Program, Inc.

US HCR118

Expressing support for the expansion of the warship manufacturing industry in Texas.

US HB675

Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 or the Domestic SUPPLY Act of 2025This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) to address infectious diseases and other public health emergencies.Specifically, the Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements with eligible domestic manufacturers for PPE to prepare for and respond to public health emergencies. To be eligible, manufacturers must be majority owned and operated by U.S. citizens and must manufacture a majority of their contracted products domestically, with 100% of products manufactured domestically by 2028. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program.In addition, the federal government must only procure, subject to limited exceptions, clothing or equipment that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure such items domestically.Further, the bill requires HHS to submit to Congress a report about changes to federal requirements for PPE since the beginning of the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.

Similar Bills

US HB7936

Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026

US HB5186

To authorize the Secretary of Defense to carry out a program to support the defense biotechnology supply chain, and for other purposes.

US HB6664

To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

MN SF3380

Bioindustrial facilities payments appropriation

MN HF3217

Payments to bioindustrial facilities funding provided, and money appropriated.

MN HF2440

Labor market trends report funding provided, and money appropriated.

MN SF1832

Omnibus Jobs, Labor Economic Development policy and appropriations

US HB3838

Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 Anti-CBDC Surveillance State Act Coast Guard Authorization Act of 2025 SAFE Research Act